Europe Sleep Apnea Devices Market Report by Products Types (Therapeutics, Diagnostics), End User, Countries and Company Analysis 2026-2034

Europe Sleep Apnea Devices Market Size & Forecast 2026-2034

Europe Sleep Apnea Devices market is expected to grow at a CAGR of 7.45% during 2026-2034 and is projected to reach 3.49 billion in 2034 from 1.83 billion in 2025. Factors such as the prevalence of sleep disorders and awareness regarding early detection and treatment are contributing to market growth. In addition, the availability of advanced therapeutic solutions for treating sleep apnea, such as CPAP and BiPAP machines, is driving market growth in Europe. The availability of homecare solutions is also contributing to market growth in Europe.

Europe Sleep Apnea Devices Market Outlooks

Sleep apnea devices are medical products used for both diagnosing and treating sleep apnea, which is a condition characterized by cessation or reduction in breathing during sleep. These products include continuous positive airway pressure devices, bilevel positive pressure devices, oral appliances, and diagnostic products such as polysomnography and portable sleep monitors. These products function by keeping the patient's breathing passages open, monitoring breathing cycles, and providing sufficient oxygen during sleep. This has a positive impact on improving sleep and reducing health risks.

The demand for sleep apnea devices in Europe has been on an upward trend due to increasing awareness of sleep disorders and their effects on health. This has resulted in a significant increase in sleep apnea patients due to a rise in lifestyle diseases such as obesity and heart diseases. Moreover, the health infrastructure in Europe is highly developed, providing easier access to these products for patients. In addition, technology has improved sleep apnea products to make them more convenient for patients. This has resulted in increased demand for these products. The home healthcare and preventative medicine trend is on the increase in Europe. This has resulted in sleep apnea devices becoming increasingly important in Europe.

Growth Drivers of the Europe Sleep Apnea Devices Market

Rising Prevalence of Sleep Disorders and Aging Population

The 60+ age group in the WHO European Region has a rapidly increasing population, from 215 million in 2021, growing to 247 million in 2030, and increasing further to over 300 million in 2050. Similarly, the 80+ age group, which is more prone to seeking help, is set to rise by more than double in 2050. In addition, the increasing rate of sleep apnea in the European region is one of the major drivers for the market. With the increasing aging population in the region, which is more prone to sleep apnea, the number of cases of sleep apnea is increasing rapidly. In addition, lifestyle changes, including obesity, physical inactivity, and high stress levels, are also contributing to the increasing rate of obstructive sleep apnea in the region. Many people in the region are becoming aware of the health risks they are facing if they have untreated sleep apnea. This has led to an increased demand for the diagnosis and treatment of sleep apnea. This has led to an increased focus on preventive medicine in the region, which in turn has led to the increased adoption of sleep apnea devices in the region.

Strong Healthcare Infrastructure and Favorable Reimbursement Policies

Europe has an established healthcare system and reimbursement environment, which is important to the growth of the sleep apnea devices market. Many countries provide partial or full reimbursement for sleep apnea diagnosis and therapy, including the cost of diagnostic tests and therapeutic devices like CPAP machines. This makes it easier and affordable for patients to seek treatment. Europe has a public healthcare system and government initiatives that ensure patients with sleep apneas are provided with diagnosis and therapy as part of their regular healthcare services. Europe has sleep clinics and healthcare professionals who provide quality healthcare services to patients with sleep apneas. This leads to the diagnosis and treatment of patients with sleep apneas. Europe has invested heavily in healthcare infrastructure and has modernized healthcare facilities. This means patients with sleep apneas have access to quality diagnosis and therapy. This is important to the growth of the sleep apnea devices market. The concept of "Open Strategic Autonomy" (OSA) has been enthusiastically endorsed by European Union policymakers in recent years as a strategy to address the pressing challenges, and the approach was initially intended to boost the EU's capacity to act independently. However, the political momentum has widened the scope of the original strategy to cover areas such as trace, technology, and health provision.

Technological Advancements and Growth of Home Healthcare

Technological advancements are significantly contributing to the growth of the sleep apnea devices market in Europe. The latest devices are more compact, quieter, and more user-friendly, making it more comfortable for patients to use. Auto-adjusting devices, wirelessly connected devices, and devices with mobile app connectivity are now available. The home healthcare segment is also contributing to the growth of the sleep apnea devices market. Patients are seeking more convenient and cost-effective options for treating sleep apnea. Portable devices for diagnosis and monitoring sleep apnea at home are now more easily available. Telemedicine is also contributing to the growth of the sleep apnea devices market. Healthcare professionals can now monitor patient progress from a distance. Research and development activities by medical device manufacturers are contributing to the growth of the sleep apnea devices market. The latest devices are more innovative, which is resulting in the widespread adoption of sleep apnea devices in Europe. Dec 2024, Nyxoah SA has launched its battery-free Genio neurostimulator for treating obstructive sleep apnea (OSA) in England. The hypoglossal neuromodulation system, which is controlled by a wearable device, is now available through the NHS Specialised Services Devices Programme.

Challenges of the Europe Sleep Apnea Devices Market

Low Awareness and Underdiagnosis in Certain Regions

Despite the general growth in the market, there is a major problem of low awareness and underdiagnosis of sleep apnea, which is affecting various countries in Europe. The general public is unaware of the symptoms and risks of sleep apnea. The symptoms, such as snoring, fatigue, and sleep deprivation, are often not taken seriously. As a result, there is an underdiagnosis of sleep apnea. In some countries, there is limited access to sleep clinics, which is also contributing to the underdiagnosis of sleep apnea. This is creating a gap between the actual number of cases of sleep apnea and the diagnosed cases, thereby affecting the growth of the sleep apnea market.

High Cost of Devices and Compliance Issues

The high cost of advanced sleep apnea therapy devices is another factor that could act as a barrier to the growth of the sleep apnea therapy market in Europe. Although reimbursement policies have reduced the cost of sleep apnea therapy in Europe, the cost is still high in some countries. Patient compliance is another factor that could act as a barrier to the growth of the sleep apnea therapy market. Sleep apnea therapy is generally uncomfortable for patients. Some patients find the machines uncomfortable because of the pressure of the air they breathe. This discomfort causes patients to fail to comply with their therapy. This is because sleep apnea therapy can only be effective if patients comply with their therapy.

Europe Sleep Apnea Therapeutic Devices Market

The Europe sleep apnea therapeutic devices market is witnessing steady growth due to the rising prevalence of sleep disorders and the demand for effective long-term treatment options. Devices such as CPAP, BiPAP, and adaptive servo-ventilatory devices are popular in the management of sleep apnea. These devices provide continuous positive airway pressure, thus facilitating the smooth flow of air. This helps in the maintenance of a high quality of sleep and minimizes the risks associated with sleep disorders. Awareness about the necessity to seek early treatment and the benefits of preventative care measures is driving the adoption rate. Improved designs and features, such as the noise levels and comfort levels of the devices, are also contributing to the growth rate. Home care services in Europe are becoming more popular, and the adoption rate for sleep apnea therapeutic devices will also increase in the coming years. Developed countries in Europe have robust healthcare infrastructure and a supportive reimbursement system.

Europe CPAP Sleep Apnea Therapeutic Devices Market

The CPAP segment leads the Europe sleep apnea therapeutic devices market because of the effectiveness of CPAP devices in treating sleep apnea. CPAP devices provide constant air flow to keep the airway open. They are the most commonly prescribed therapy for sleep apnea. The rising rate of sleep apnea diagnoses and the clinical recommendation of CPAP therapy drive the CPAP device market in Europe. The advancements in CPAP devices, such as auto-adjusting pressure, integrated humidification systems, and advanced masks, increase the comfort of the users. Moreover, the use of technology in CPAP devices helps the doctors remotely monitor the patient's progress. The availability of various CPAP devices to treat sleep apnea in patients makes the CPAP segment the leader in the Europe sleep apnea therapeutic devices market. Despite the challenges posed by patient compliance with CPAP therapy, CPAP devices remain the mainstay in the treatment of sleep apnea.

Europe Sleep Apnea Polysomnography Devices Market

Polysomnography devices are critical in the diagnosis of sleep apnea and sleep disorders in Europe. Therefore, this segment is an integral part of the European sleep apnea diagnostics market. These devices are utilized in sleep laboratories and hospitals to measure several physiological parameters simultaneously. These parameters include the activity in the brain, breathing patterns, levels of oxygen in the blood, and heart rate. The rising awareness of sleep disorders and the necessity for accurate diagnosis of the condition are fueling the demand for polysomnography devices. These devices help health care providers verify the condition and design the course of action necessary for the patient. The evolution of technology has improved the efficiency of sleep studies. Therefore, the use of polysomnography devices is gaining traction. The rise of special sleep clinics in Europe has further fueled the growth of the sleep apnea diagnostics market. Although in-lab sleep studies are considered the gold standard for the diagnosis of the condition, the availability of portable polysomnography devices has improved the convenience of the procedure.

Europe Sleep Apnea Oximeter Devices Market

The Europe sleep apnea oximeter devices market is witnessing growth due to the increasing demand for simple and non-invasive monitoring devices. Pulse oximeters are commonly used to measure the blood oxygen saturation levels during sleep to detect and monitor sleep apnea. Pulse oximeters have become very popular, especially to be used at home due to their cost-effectiveness, simplicity, and portability. The trend towards home healthcare is driving the demand for oximeter devices. Oximeter devices are witnessing an increased demand due to their growing popularity and the trend towards home healthcare.

Europe Sleep Apnea Devices Clinics & Hospitals Market

The role of clinics and hospitals is significant in the Europe sleep apnea devices market. These facilities are important for providing complete diagnostic and therapeutic services for patients. Clinics and hospitals are equipped with advanced technology for diagnostic and therapeutic purposes. For instance, polysomnography systems are used for diagnostic purposes. Moreover, these facilities have highly skilled healthcare practitioners and teams to deliver high-quality patient services. The increase in investments in healthcare infrastructure and specialized sleep clinics in Europe is another factor contributing to market growth. In addition, reimbursement policies are in place for diagnostic and therapeutic procedures carried out in clinics. With increasing awareness of sleep disorders, clinics and hospitals are contributing to market growth for sleep apnea devices.

France Sleep Apnea Devices Market

The France sleep apnea devices market is growing and has been boosted by the country's well-developed public healthcare system and the rising awareness of sleep disorders. France has a high rate of sleep apnea, especially in the elderly and those suffering from lifestyle disorders. Government initiatives in the form of healthcare schemes and financial support for sleep apnea patients using sleep devices also contribute to the growth of the sleep apnea devices market in France. Sleep disorders, such as sleep apnea, require sleep tests and CPAP therapy, which are common in France. France also has a high number of well-developed and well-equipped hospitals and sleep centers. Home healthcare products also contribute to the growth of the sleep apnea devices market in France. Patients seek home healthcare products because they are cost-effective and easy to use. Sleep apnea devices in France will grow in the coming years due to the rising awareness and healthcare support. July 2024, Inspire Medical Systems, Inc. today announced the publication of the reimbursement for its innovative therapy for obstructive sleep apnea in France.

Germany Sleep Apnea Devices Market

Germany is one of the major markets for sleep apnea devices in the European region, especially because of its advanced medical technology and high diagnosis rate for sleep apnea. In addition, the country has a high standard of medical infrastructure, including well-equipped hospitals and diagnosis centers for sleep apnea. It is also known for its high rate of technology innovation, thus leading to the implementation of advanced CPAP devices. In addition, favorable reimbursement policies have encouraged more patients to seek treatment for sleep apnea. It is also noteworthy that several medical device manufacturers have set up base in the country, thus encouraging growth in the sleep apnea devices market. In conclusion, Germany has shown promise in terms of its growth in the sleep apnea devices market. As it continues to innovate in the medical field, it is anticipated that the sleep apnea devices market will keep growing in the country. Dec. 2024, Eli Lilly announced that the FDA has approved Zepbound(R) (tirzepatide), the first prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. Zepbound has the potential to improve sleep disorders with a reduced-calorie diet and increased physical activity.

United Kingdom Sleep Apnea Devices Market

The United Kingdom sleep apnea devices market is growing at a steady rate, with increasing awareness of sleep disorders and the contribution of the National Health Service (NHS) in providing quality healthcare services. The NHS has a significant contribution in providing quality services in terms of diagnosis and treatment options like CPAP therapy for sleep apnea patients. In addition, the rise in obesity and cardiovascular diseases is increasing the prevalence of sleep apnea in the United Kingdom. Awareness campaigns and recommendations from medical professionals are increasing the rate of early diagnosis of sleep apnea. Furthermore, the rise in sleep disorder clinics and the introduction of home-based diagnosis equipment are increasing the accessibility rate for sleep apnea diagnosis. Despite challenges like public healthcare service waiting times, the United Kingdom is improving its services, thus increasing the growth rate of the sleep apnea devices market. The United Kingdom is a major country in the sleep apnea devices market in the European region. March 2026, A newly developed implantable medical device for treating moderate to severe obstructive sleep apnoea (OSA) is being rolled out in several major London hospitals, representing a major milestone in the country's development in sleep disorder technology.

Russia Sleep Apnea Devices Market

The Russia sleep apnea devices market is at a developing stage, with promising growth opportunities. Investments in healthcare and increased awareness of sleep apnea are contributing to the growth of this market. Although there is relatively lower awareness compared to Western European countries, there is an increased trend towards improving levels of awareness through educational campaigns and increased medical services. The incidence of sleep apnea is also on the rise, mainly due to lifestyle changes and an increasing elderly population. The urban population is showing increased adoption of devices for diagnosis and treatment of sleep apnea. The expansion of private sector medical facilities is also contributing to increased access to sleep apnea treatments. However, there is limited access to advanced technologies, as well as cost factors. Additionally, there is an import dependency for medical devices, which can impact costs. Nevertheless, with increased investments in healthcare and levels of awareness, there is promise for growth in the Russia sleep apnea devices market.

Europe Sleep Apnea Devices Market Segments

Types - Market breakup from 2 viewpoints:

1. Therapeutic Devices

2. Diagnostic Devices

Therapeutic Devices

1. CPAP Sleep Apnea Therapeutic Devices

2. Auto CPAP Sleep Apnea Therapeutic Devices

3. BiPAP Sleep Apnea Therapeutic Devices

4. Adaptive Servo-Ventilation (ASV)

Diagnostic Devices

1. Polysomnography Devices (PSG)

2. Oximeter

3. Actigraphy Monitoring Device

4. Respiratory Polygraph

5. Sleep Apnea Screening Device

End User

1. Sleep Laboratories, Clinics & Hospitals

2. Home Care Settings/Individuals

Country:

1. France

2. Germany

3. Italy

4. Spain

5. United Kingdom

6. Belgium

7. Netherlands

8. Russia

9. Poland

10. Greece

11. Norway

12. Romania

13. Portugal

14. Rest of Europe

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysi

Key Players Analysis

1. Natus Medical Incorporated

2. ResMed Inc.

3. Somnomed

4. Apex Medical Corporation

5. Koninklijke Philips N.V.

6. Compumedics

7. Fisher &Paykel Healthcare

8. Nyxoah SA